4 results match your criteria: "Fourth Military Medical UniversityXi'an 710032[Affiliation]"

Melatonin represses oral squamous cell carcinoma metastasis by inhibiting tumor-associated neutrophils.

Am J Transl Res

December 2017

State Key Laboratory of Military Stomatology, Department of Oral and Maxillofacial Surgery, School of Stomatology, Fourth Military Medical UniversityXi'an 710032, Shannxi, China.

Tumor-associated neutrophils (TANs) promote metastasis of multiple cancers, including oral squamous cell carcinoma (OSCC). Melatonin (Mel) reportedly exerts anti-metastatic effects on OSCC. However, little is known about the anti-OSCC effects of Mel involved in TANs.

View Article and Find Full Text PDF

Our study aims to investigate the effects of the inhalation of subanesthestic doses of sevoflurane combined with oxygen on sepsis. Male Sprague-Dawley rats or Male ICR/Km mice underwent caecal ligation and puncture (CLP) or intraperitoneal injection of lipopolysccharide (LPS) to induce sepsis, while sham rats were used as control. Then, rats were treated with the inhalation of sevoflurane in oxygen; and air or 100% oxygen was used as control.

View Article and Find Full Text PDF

Polypeptide APP8 is a prostate-specific antigen (PSA)-activated prodrug that was designed to synergize the effects of the Bcl-2 homology domain 3 (BH3) peptide, K237 and the DG2 peptide. The aim of this study is to evaluate its biodistribution and anticancer effect in vitro and in vivo. In this study, APP8 and each component peptide were synthesized.

View Article and Find Full Text PDF

KyoT2 downregulates airway remodeling in asthma.

Int J Clin Exp Pathol

October 2016

Department of Respiratory Medicine, Xijing Hospital, Fourth Military Medical University Xi'an 710032, China.

Article Synopsis
  • The study investigates KyoT2's role in asthma, focusing on airway remodeling and hyperresponsiveness.
  • KyoT2, which inhibits Notch signaling, was tested on asthmatic mice to assess its effects on airway structure and resistance.
  • Results showed that KyoT2 reduces Hes1 expression, lessens airway remodeling, and improves hyperresponsiveness, suggesting it could be a viable treatment for asthma.
View Article and Find Full Text PDF